Identification | Back Directory | [Name]
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- | [CAS]
145591-80-6 | [Synonyms]
Cabozantinib impurity 3 Cabozantinib impurities3 1-(phenylcarbamoyl)cyclopropanecarboxylic acid 1-(phenylcarbamoyl)cyclopropane-1-carboxylic acid 1-(phenylaMinocarbonyl)cyclopropanecarboxylic acid Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- | [Molecular Formula]
C11H11NO3 | [MDL Number]
MFCD16669493 | [MOL File]
145591-80-6.mol | [Molecular Weight]
205.21 |
Chemical Properties | Back Directory | [Boiling point ]
480.3±28.0 °C(Predicted) | [density ]
1.439±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
3.62±0.20(Predicted) | [color ]
White to Off-White |
Hazard Information | Back Directory | [Uses]
1-(Phenylcarbamoyl)cyclopropane-1-carboxylic Acid can be useful in the synthesis and evaluation of novel oral multi-kinase inhibitor for treatment of solid tumor. |
|
Company Name: |
SPIRO PHARMA
|
Tel: |
|
Website: |
www.spiropharma.com.cn |
|